Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular ...

A cardiovascular disease (CVD) risk prediction tool developed by Northwestern Medicine scientists may also be effective for identifying which patients would most benefit from statin therapy, according ...

In this study, we investigated the acute effects of tadalafil citrate at peak serum level on the CVS by evaluating serum oxidative status and PON-1 enzyme activity. This study included 36 patients ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

This Monday (1 September) at the European Society of Cardiology (ESC) meeting in Madrid, the link between dietary intake, leg ...

Many cases of cardiovascular disease are preventable through early detection and intervention.   In the DANCAVAS 2 population-based trial, being invited to undergo comprehensive cardiovascular ...